多维元素片(29)致甲状腺功能异常

来源 :药物不良反应杂志 | 被引量 : 0次 | 上传用户:laotzu123
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
1例29岁女性患者因准备怀孕服用多维元素片(29)(每片含碘150 μg)近1年。孕前检查发现甲状腺功能异常,游离甲状腺素(FTn 4)23.2 pmol/L,游离三碘甲状腺原氨酸(FTn 3)5.56 pmol/L,促甲状腺激素(TSH)0.10 mU/L。遵医嘱立即停用多维元素片(29)。停用该药5 d后复查甲状腺功能仍异常,FTn 4 21.2 pmol/L,FTn 3 5.39 pmol/L,TSH 0.08 mU/L,促甲状腺素受体抗体<0.3 U/L;停药59 d后复查,甲状腺功能恢复正常,FTn 4 16.35 pmol/L,FTn 3 4.97 pmol/L,TSH 2.36 mU/L,考虑患者的甲状腺功能异常为多维元素片(29)所致。n “,”A 29-year-old female patient took vitamins with minerals tablets (29) (each tablet contains 150 μg of iodine) for nearly one year because she was preparing for pregnancy. Abnormal thyroid function was found in pre-pregnancy examination. Her free thyroxine (FT n 4) was 23.2 pmol/L, free triiodothyronine (FTn 3) was 5.56 pmol/L, and thyroid stimulating hormone (TSH) was 0.10 mU/L. According to the doctor′s advice, she stopped taking vitamins with minerals tablets (29) immediately. Five days after discontinuation of the drug, her FTn 4 was 21.2 pmol/L, FTn 3 was 5.39 pmol/L, TSH was 0.08 mU/L, and thyrotropin receptor antibody was <0.3 U/L. The results of re-examination on day 59 after drug withdrawal showed FT n 4 16.35 pmol/L, FTn 3 4.97 pmol/L, and TSH 2.36 mU/L. It was considered that the patient′s thyroid dysfunction was caused by vitamins with minerals tablets (29).n
其他文献
1例31岁男性患者因肺部感染给予莫西沙星400 mg口服、1次/d。用药9 d后出现咯血、便血和全身散在瘀点、瘀斑,血小板计数(PLT)1×10n 9/L,诊断为血小板减少性紫癜。停用莫西沙
1例55岁男性肝复杂泡型包虫病患者有痛风病史4年余,入院等待远程会诊结果和准备接受择期右半肝切除术时,出现双足肿胀、皮温高等症状。实验室检查示尿酸530 μmol/L,风湿因子阴
1例63岁男性患者因膀胱癌肺转移接受纳武单抗(1 mg/kg)和伊匹木单抗(3 mg/kg)静脉滴注,1次/21 d。第2次用药后第3天,患者出现发作性胸闷,平卧数分钟后可自行缓解,实验室检查示超敏肌
3例患者(例1女,52岁,有甲型肝炎史;例2女,64岁;例3女,61岁)均因慢性胃炎给予摩罗丹(浓缩丸)16丸口服、3次/d。例1无合并用药,例2合并使用雷贝拉唑钠肠溶片,例3合并使用雷贝拉唑钠肠溶片
1例59岁男性患者因胃癌伴多发淋巴结转移接受SOX方案化疗:奥沙利铂注射液200 mg入5%葡萄糖注射液250 ml静脉滴注2 h(第1天),替吉奥60 mg口服、2次/d(第1~14 d);每3周为1个周期。在第